Cytophage Technologies Ltd. (TSXV:CYTO)
Canada · Delayed Price · Currency is CAD 0.1750
-0.0050 (-2.78%)
Jan 21, 2026, 10:45 AM EST
Cytophage Technologies Company Description
Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.
It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name.
The company is headquartered in Oak Bluff, Canada.
Cytophage Technologies Ltd.
| Country | Canada |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Steven Theriault |
Contact Details
Address: 400 Fort Whyte Way Oak Bluff, MB R4G 0B1 Canada | |
| Website | cytophage.com |
Stock Details
| Ticker Symbol | CYTO |
| Exchange | TSX Venture Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Steven Theriault B.Sc., M.Sc., Ph.D. | Chief Executive Officer, Chief Science Officer and Director |
| Julius John Kalcevich M.B.A. | Chief Financial Officer |
| Heather Medwick B.A. | Chief Operating Officer |